There are currently no events scheduled. Please check back again soon.
Date: June 12-16, 2017 Website: World Preclinical Congress Location: Boston, MA
Date: June 6-7, 2017 Website: LD Micro Invitational Location: Bel Air, CA Corporate Presentation: Tuesday, June 6th at 11:30 am PT webcast
Date: June 2-6, 2017 Website: ASCO Annual Meeting Location: Chicago, IL
Date: May 24-25, 2017 Website: Precision Medicine World Conference (PMWC) Conference Location: Duke University – Durham, NC Presentation: How AI is Accelerating and Enabling Precision Oncology As the oncology industry moves towards precision medicine, massive data are being used to increase the accuracy and speed of clinical care, improve insights for targeted drug […]
Date: March 16-17, 2017 Website: BMS Annual R&D Symposium Location: Somerset, NJ
Date: May 2-4, 2017 Website: Biomarkers and Diagnostics World Congress Location: Philadelphia, PA
Date: May2-3, 2017 Website: Executive War College Location: New Orleans, Louisiana Presentation: Growing A Cancer Diagnostics Company in Today’s Fast-changing Environment: How We Leverage New Technologies and Collaborations to Win Clinical Acceptance and Increase Market Share Panna Sharma, President & CEO, Cancer Genetics, Inc.
Date: April 4, 2017 Website: The MicroCap Conference Location: New York, New York Corporate Presentation: Tuesday, April 4th – 8:00 AM Eastern webcast
Date: April 1-5, 2017 Website: AACR 2017 Location: Washington, DC
Date: March 20-21, 2017 Website: Central Labs & Diagnostics Conference Location: Philadelphia, PA Presentation: Choose a Central Lab with Access to Genomic Assays to Warrant the Right Number and Right Kind of Patients in Your Clinical Trial Speaker: Kamala Maddali, DVM, Ph.D. Vice President, Biopharma Collaborations and Companion Diagnostics Cancer Genetics, Inc.
Date: March 20-22, 2017 Website: GTC Biomarker Summit Location: San Diego, CA
Date: March 17, 2017 Website: A Future Without Cancer Location: Palm Beach, Florida
Date: February 22-24, 2017 Website: NGS Symposium Location: Hyderabad, India Hosted By: CG India and CCMB
Date: February 19-24, 2017 Website: Molecular Med Tri-Con Location: San Francisco, CA 24th International Molecular Med Tri-Con 2017: Attracting over 3,500 drug discovery and development professionals from over 40 countries in 2016, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
Date: February 10-11, 2017 Website: MPAI Conference Location: Bhubaneswar, India ABSTRACT: Integrating Cancer Genomics and Pathology in Clinical Service to Assist in Better Treatment Regimens for Oncology Patients – Case Studies Kishor Bhatia, Kamala Maddali, Anna Israyelyan, Rita Shaknovich, Rob, Fannon, Narasimha Marella, Mandhar Kulkarni and Rama Modali. The rapid gain of knowledge […]
Date: February 6-7, 2017 Website: Biomarker Conference Location: San Diego, CA Session Chair: Kamala Maddali, DVM, Ph.D. Vice President, Biopharma Collaborations and Companion Diagnostics Cancer Genetics, Inc. Speaker Presentation: CGIX on Immuno-Oncology Biomarker evaluation in Solid and hematologic cancers: value of a focused vs. broad approach; role in multi-modality testing, […]
Date: January 28, 2017 Website: 4th Annual USC Multi-Disciplinary Breast Cancer Symposium Location: Los Angeles, CA
Date: January 25-26, 2017 Website: Sample, Lab and Diagnostics Services in Clinical Trials Location: Miami, Florida Panel Session: Interactive Discussion: Biobanks to Serve Clinical Trials Operational considerations: Sample procurement, identification and de-identification Regulatory considerations Running in-house biobanks Partnering with commercial biobanks Panelists: Kamala Maddali, DVM, Ph.D. […]
Date: December 3 – 6, 2016 Booth #: 4543 Website: American Society of Hematology Location: San Diego, California
Date: December 2, 2016 Website: Inspiring Women in STEM Conference Location: Bridgewater, NJ Panel Session: Building a Culture of Empowerment in a Multi-Generational Workforce Panelist: Kamala Maddali, DVM, Ph.D. Vice President, Biopharma Collaborations and Companion Diagnostics Cancer Genetics, Inc.